These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 11665975

  • 21. International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies.
    Bentow C, Lakos G, Martis P, Wahl E, Garcia M, Viñas O, Espinosa G, Cervera R, Sjöwall C, Carmona-Fernandes D, Santos MJ, Hanly JG, Mahler M.
    Lupus; 2016 Jul; 25(8):864-72. PubMed ID: 27252263
    [Abstract] [Full Text] [Related]

  • 22. A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.
    Wallace DJ, Stohl W, Furie RA, Lisse JR, McKay JD, Merrill JT, Petri MA, Ginzler EM, Chatham WW, McCune WJ, Fernandez V, Chevrier MR, Zhong ZJ, Freimuth WW.
    Arthritis Rheum; 2009 Sep 15; 61(9):1168-78. PubMed ID: 19714604
    [Abstract] [Full Text] [Related]

  • 23. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH.
    Lupus; 2012 Jan 15; 21(1):36-42. PubMed ID: 21993384
    [Abstract] [Full Text] [Related]

  • 24. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R, Goyal LK, Agrawal A, Mehta A, Mittal P, Yadav RN, Meena PD, Wadhvani D.
    J Assoc Physicians India; 2013 Jun 15; 61(6):372-7. PubMed ID: 24640201
    [Abstract] [Full Text] [Related]

  • 25. Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity.
    Andrejevic S, Jeremic I, Sefik-Bukilica M, Nikolic M, Stojimirovic B, Bonaci-Nikolic B.
    Clin Rheumatol; 2013 Nov 15; 32(11):1619-26. PubMed ID: 23857662
    [Abstract] [Full Text] [Related]

  • 26. Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study.
    Petri M, Singh S, Tesfasyone H, Malik A.
    J Rheumatol; 2009 Nov 15; 36(11):2476-80. PubMed ID: 19833757
    [Abstract] [Full Text] [Related]

  • 27. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
    Furie R, Petri M, Zamani O, Cervera R, Wallace DJ, Tegzová D, Sanchez-Guerrero J, Schwarting A, Merrill JT, Chatham WW, Stohl W, Ginzler EM, Hough DR, Zhong ZJ, Freimuth W, van Vollenhoven RF, BLISS-76 Study Group.
    Arthritis Rheum; 2011 Dec 15; 63(12):3918-30. PubMed ID: 22127708
    [Abstract] [Full Text] [Related]

  • 28. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
    Matrat A, Veysseyre-Balter C, Trolliet P, Villar E, Dijoud F, Bienvenu J, Fabien N.
    Lupus; 2011 Jan 15; 20(1):28-34. PubMed ID: 20943718
    [Abstract] [Full Text] [Related]

  • 29. What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3.
    Flechsig A, Rose T, Barkhudarova F, Strauss R, Klotsche J, Dähnrich C, Schlumberger W, Enghard P, Burmester GR, Hiepe F, Biesen R.
    Clin Exp Rheumatol; 2017 Jan 15; 35(4):598-606. PubMed ID: 28281463
    [Abstract] [Full Text] [Related]

  • 30. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.
    ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG.
    Arthritis Rheum; 1990 May 15; 33(5):634-43. PubMed ID: 2346519
    [Abstract] [Full Text] [Related]

  • 31. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
    Zen M, Bassi N, Nalotto L, Canova M, Bettio S, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A.
    Clin Exp Rheumatol; 2012 May 15; 30(6):856-63. PubMed ID: 22765883
    [Abstract] [Full Text] [Related]

  • 32. [Detection of dsDNA antibodies in diagnosis of systemic lupus erythematosus--comparative studies of diagnostic effectiveness of 3 ELISA methods with different antigens and a Crithidia luciliae immunofluorescence test].
    Wigand R, Gottschalk R, Falkenbach A, Matthias T, Kaltwasser JP, Hoelzer D.
    Z Rheumatol; 1997 May 15; 56(2):53-62. PubMed ID: 9235810
    [Abstract] [Full Text] [Related]

  • 33. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.
    Miyawaki S, Nishiyama S, Aita T, Yoshinaga Y.
    Mod Rheumatol; 2013 Jul 15; 23(4):659-66. PubMed ID: 23011357
    [Abstract] [Full Text] [Related]

  • 34. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.
    Picard C, Lega JC, Ranchin B, Cochat P, Cabrera N, Fabien N, Belot A.
    Pediatr Nephrol; 2017 Sep 15; 32(9):1537-1545. PubMed ID: 28343355
    [Abstract] [Full Text] [Related]

  • 35. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation.
    Bootsma H, Spronk PE, Ter Borg EJ, Hummel EJ, de Boer G, Limburg PC, Kallenberg CG.
    Ann Rheum Dis; 1997 Nov 15; 56(11):661-6. PubMed ID: 9462168
    [Abstract] [Full Text] [Related]

  • 36. Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus.
    Biesen R, Dähnrich C, Rosemann A, Barkhudarova F, Rose T, Jakob O, Bruns A, Backhaus M, Stöcker W, Burmester GR, Schlumberger W, Egerer K, Hiepe F.
    Arthritis Res Ther; 2011 Feb 10; 13(1):R26. PubMed ID: 21329504
    [Abstract] [Full Text] [Related]

  • 37. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study.
    Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA.
    Rheumatology (Oxford); 2001 Dec 10; 40(12):1405-12. PubMed ID: 11752513
    [Abstract] [Full Text] [Related]

  • 38. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA, Abaza NM, Hammam N, Mohamed AAA, El-Gazzar II, Eissa AH.
    Lupus; 2018 Jun 10; 27(7):1081-1087. PubMed ID: 29460701
    [Abstract] [Full Text] [Related]

  • 39. Low frequency of flares during pregnancy and post-partum in stable lupus patients.
    Davis-Porada J, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Sawitzke A, Merrill JT, Buyon JP, Salmon JE.
    Arthritis Res Ther; 2020 Mar 19; 22(1):52. PubMed ID: 32188491
    [Abstract] [Full Text] [Related]

  • 40. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
    Lim KL, Jones AC, Brown NS, Powell RJ.
    Ann Rheum Dis; 1993 Jun 19; 52(6):429-35. PubMed ID: 8323394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.